Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL.
Savage KJ, Slack GW, Mottok A, Sehn LH, Villa D, Kansara R, Kridel R, Steidl C, Ennishi D, Tan KL, Ben-Neriah S, Johnson NA, Connors JM, Farinha P, Scott DW, Gascoyne RD.
Savage KJ, et al. Among authors: connors jm.
Blood. 2016 May 5;127(18):2182-8. doi: 10.1182/blood-2015-10-676700. Epub 2016 Feb 1.
Blood. 2016.
PMID: 26834242
Free article.